ClinConnect ClinConnect Logo
Search / Trial NCT06887998

The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery.

Launched by CAIRO UNIVERSITY · Mar 19, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Emergence Agitation Gabapentin Nasal Surgery

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients (male/female, American Society of Anesthesiologists physical status I-II, age: 18-60 years) undergoing elective nasal surgery will be eligible for the study.
  • Exclusion Criteria:
  • 1. hypersensitivity to gabapentin
  • 2. patient refusal
  • 3. epilepsy
  • 4. neurological or psychological conditions that impair communication.
  • 5. current use of gabapentin, psychotropic or opioids medications.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported